biotech · Chronic Peripheral Neuropathy Pain in Diabetics · Diabetic Peripheral Neuropathy · XTLB
XTL BIOPHARMACEUTICALS
XTL BIOPHARMACEUTICALS LTD
XTL Biopharmaceuticals is a biotech organization headquartered in Raanana, USA. It trades on NYSE under ticker XTLB. Primary therapeutic focus areas include Chronic Peripheral Neuropathy Pain in Diabetics, Diabetic Perip
Raanana, USA HQ
1993 Founded
3 Employees
Public company Type
XTLB · NYSE Ticker
Company details
- Status
- Public
- HQ
- Raanana, USA
- Founded
- 1993
- Employees
- 3
- Programs
- 4
- Drugs
- 1
- Patents
- 7
XTL 6865
Phase 1 · small molecule · Hepatitis C
XTL 6865 for Hepatitis C is a Phase 1 program (small_molecule) at XTL BIOPHARMACEUTICALS LTD with 1 ClinicalTrials.gov record(s).
Internal code XTL2005-16
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- XTL BIOPHARMACEUTICALS LTD
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Hepatitis C
- Status
- active
- Trials
- 1